?>
Logo

IMPRIMIS PHARMACEUTICALS 401(K) PLAN 401k Plan overview

Plan NameIMPRIMIS PHARMACEUTICALS 401(K) PLAN
Plan identification number 002

IMPRIMIS PHARMACEUTICALS 401(K) PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
  • Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

IMPRIMIS PHARMACEUTICALS, INC. has sponsored the creation of one or more 401k plans.

Company Name:IMPRIMIS PHARMACEUTICALS, INC.
Employer identification number (EIN):450567010
NAIC Classification:541990
NAIC Description:All Other Professional, Scientific, and Technical Services

Additional information about IMPRIMIS PHARMACEUTICALS, INC.

Jurisdiction of Incorporation: State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number: 4092296

More information about IMPRIMIS PHARMACEUTICALS, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan IMPRIMIS PHARMACEUTICALS 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0022019-01-01
0022018-01-01ANDREW BOLL2019-10-15
0022017-01-01ANDREW BOLL2018-10-15
0022016-01-01ANDREW BOLL2017-10-11
0022015-01-01ANDREW BOLL2016-10-05 ANDREW BOLL2016-10-05
0022014-01-01ANDREW BOLL2015-10-05

Plan Statistics for IMPRIMIS PHARMACEUTICALS 401(K) PLAN

401k plan membership statisitcs for IMPRIMIS PHARMACEUTICALS 401(K) PLAN

Measure Date Value
2019: IMPRIMIS PHARMACEUTICALS 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-01150
Total number of active participants reported on line 7a of the Form 55002019-01-01128
Number of retired or separated participants receiving benefits2019-01-010
Number of other retired or separated participants entitled to future benefits2019-01-0140
Total of all active and inactive participants2019-01-01168
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-010
Total participants2019-01-01168
Number of participants with account balances2019-01-01131
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-010

Financial Data on IMPRIMIS PHARMACEUTICALS 401(K) PLAN

Measure Date Value
2019 : IMPRIMIS PHARMACEUTICALS 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$2,086,486
Total loss/gain on sale of assets2019-12-31$18,606
Total of all expenses incurred2019-12-31$296,197
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$293,588
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$1,149,791
Value of total assets at end of year2019-12-31$5,528,218
Value of total assets at beginning of year2019-12-31$3,737,929
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$2,609
Total interest from all sources2019-12-31$2,670
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$1,806
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$103
Administrative expenses professional fees incurred2019-12-31$700
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$500,000
If this is an individual account plan, was there a blackout period2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$601,856
Participant contributions at end of year2019-12-31$64,542
Participant contributions at beginning of year2019-12-31$56,038
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$223,993
Value of other receiveables (less allowance for doubtful accounts) at end of year2019-12-31$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year2019-12-31$0
Other income not declared elsewhere2019-12-31$2,272
Administrative expenses (other) incurred2019-12-31$1,909
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$1,790,289
Value of net assets at end of year (total assets less liabilities)2019-12-31$5,528,218
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$3,737,929
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$0
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$9,217
Value of interest in pooled separate accounts at end of year2019-12-31$5,069,029
Value of interest in pooled separate accounts at beginning of year2019-12-31$3,477,255
Interest on participant loans2019-12-31$2,561
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year2019-12-31$168,173
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year2019-12-31$4,051
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year2019-12-31$4,051
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)2019-12-31$109
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2019-12-31$178,551
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2019-12-31$66,541
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$1,584
Net investment gain/loss from pooled separate accounts2019-12-31$909,757
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31Yes
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$323,942
Employer contributions (assets) at end of year2019-12-31$47,923
Employer contributions (assets) at beginning of year2019-12-31$23,947
Income. Dividends from common stock2019-12-31$1,703
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$293,588
Assets. Corporate common stocks other than exployer securities at end of year2019-12-31$0
Assets. Corporate common stocks other than exployer securities at beginning of year2019-12-31$100,880
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Aggregate proceeds on sale of assets2019-12-31$160,215
Aggregate carrying amount (costs) on sale of assets2019-12-31$141,609
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31KMJ CORBIN & COMPANY, LLP
Accountancy firm EIN2019-12-31810569753

Form 5500 Responses for IMPRIMIS PHARMACEUTICALS 401(K) PLAN

2019: IMPRIMIS PHARMACEUTICALS 401(K) PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – InsuranceYes
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement – InsuranceYes
2019-01-01Plan benefit arrangement - TrustYes

Insurance Providers Used on plan

MUTUAL OF AMERICA LIFE INSURANCE COMPANY (National Association of Insurance Commissioners NAIC id number: 88668 )
Policy contract number061105-K
Policy instance 1
Insurance contract or identification number061105-K
Number of Individuals Covered131
Insurance policy start date2019-01-01
Insurance policy end date2019-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $6,235
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?No
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
Commission paid to Insurance BrokerUSD $0
Amount paid for insurance broker fees6235
Additional information about fees paid to insurance brokerPORTION OF INCENTIVE COMP. PROGRAM
Insurance broker organization code?3

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3